To include your compound in the COVID-19 Resource Center, submit it here.

Enleofen co-founders identify IL-11 as pulmonary fibrosis target

DISEASE CATEGORY: Pulmonary

INDICATION: Pulmonary fibrosis

A National Heart Centre Singapore team led by Enleofen Bio Pte. Ltd. co-founders

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE